● LIVEResearch grant for the advancement of our phage therapy/GMP-certified drug production in preparation/WHO classifies AMR as a global health threat/Research and development in bacteriophage biology/● LIVEResearch grant for the advancement of our phage therapy/GMP-certified drug production in preparation/WHO classifies AMR as a global health threat/Research and development in bacteriophage biology/
    Delta G Avaris

    News

    We offer a complete package — also for the media.

    Good news and important updates – stay informed in our News section

    Bakteriophagen-Plaques – GMP-ProduktionCompany News

    Delta G Avaris acquires GMP production site of Richter Biologics in Hannover for phage manufacturing

    Effective May 1, 2026, Delta G Avaris has acquired the GMP production site of Richter Biologics in Hannover, expanding its bacteriophage manufacturing capabilities.

    05/01/2026

    ESCMID Global 2026Conference

    Participation at ESCMID Global 2026: Advances in Phage Therapy from Hannover

    Hannover Medical School presented current results on the clinical application of bacteriophages at the ESCMID Global Congress in Munich.

    04/22/2026

    BSFZ-Siegel 2026 – ForschungszulageResearch & Development

    Delta G Avaris receives approximately €900,000 in research funding for the further development of phage therapy

    Funding of approximately €900,000 for research and development activities in the field of phage therapy.

    04/07/2026

    WISO – ZDF WirtschaftsmagazinMedia Coverage

    WISO report by ZDF

    Be inspired by the fascinating capabilities of phage therapy - in the interview from minute 16:22 to 22:02.

    Read More

    10/27/2025

    Contact

    Press Contact

    For press inquiries and media inquiries, please contact our communications department.

    We use cookies to provide you with the best possible experience on our website. Learn more